The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Estimating future hepatitis C morbidity, mortality, and costs in the United States
Open accessAbstract
OBJECTIVES: This study estimated future morbidity, mortality, and costs resulting from hepatitis C virus (HCV). METHODS: We used a computer cohort simulation of the natural history of HCV in the US population. RESULTS: From the year 2010 through 2019, our model projected 165,900 deaths from chronic liver disease, 27,200 deaths from hepatocellular carcinoma, and $10.7 billion in direct medical expenditures for HCV. During this period, HCV may lead to 720,700 years of decompensated cirrhosis and hepatocellular carcinoma and to the loss of 1.83 million years of life in those younger than 65 at a societal cost of $21.3 and $54.2 billion, respectively. In sensitivity analysis, these estimates depended on (1) whether patients with HCV and normal transaminase levels develop progressive liver disease, (2) the extent of alcohol ingestion, and (3) the likelihood of dying from other causes related to the route of HCV acquisition. CONCLUSIONS: Our results confirm prior Centers for Disease Control and Prevention projections and suggest that HCV may lead to a substantial health and economic burden over the next 10 to 20 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Healthy People 2000: National Health Promotion and Disease Prevention Objectives.
Heidel], [. (1991) · Population and Development Review · doi:10.2307/1971966 · Cited by 3,155
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Self-citationThe Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,992
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Classification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593
Markov Models in Medical Decision Making: A Practical Guide
Sonnenberg, F. A., & Beck, J. R. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300409 · Cited by 2,419
Surveillance for waterborne-disease outbreaks--United States, 1993-1994.
Kramer, M. H., Herwaldt, B. L., Craun, G. F., Calderon, R. L., & Juranek, D. D. (1996) · PubMed · Cited by 2,152
Okuda, K., Ohtsuki, T., Obata, H., Tomimatsu, M., Okazaki, N., Hasegawa, H., Nakajima, Y., & Ohnishi, K. (1985) · Cancer · doi:10.1002/1097-0142(19850815)56:4<918::aid-cncr2820560437>3.0.co;2-e · Cited by 1,931
Fattovich, G., Giustina, G., Degos, F., Tremolada, F., Diodati, G., Almasio, P., Nevens, F., Solinas, A., Mura, D., Brouwer, J., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024300 · Cited by 1,399
The Distinction Between Cost and Charges
FINKLER, S. A. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-1-102 · Cited by 1,052
The Markov process in medical prognosis
Beck, J. R., & Pauker, S. G. (1983) · Medical Decision Making · doi:10.1177/0272989x8300300403 · Cited by 957 · cited 3×
“We used a Markov computer simulation to model prognosis by following up over time a cohort representative of the HCV-infected cohorts for each age group within the National Health and Nutrition Examination Survey III (NHANES III).(14,15) Details of the computer model have been published elsewhere.”
MethodHepatitis C: the clinical spectrum of disease.
Hoofnagle, J. H. (1997) · Hepatology · doi:10.1002/hep.510260703 · Cited by 765
Soto, B., Sánchez-Quijano, A., Rodrigo, L., Olmo, J. A. D., García-Bengoechea, M., Hernández-Quero, J., Rey, C., Abad, M. A., Rodríguez, M., Sales Gilabert, M., et al. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80001-3 · Cited by 701
EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999
(1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80154-8 · Cited by 700
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
Seeff, L. B., Buskell-Bales, Z., Wright, E. C., Durako, S. J., Alter, H. J., Iber, F. L., Hollinger, F. B., Gitnick, G., Knodell, R. G., Perrillo, R. P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272703 · Cited by 672
Boring, C. C., Squires, T. S., & Tong, T. (1991) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.41.1.19 · Cited by 617
(1997) · Hepatology · doi:10.1002/hep.510260701 · Cited by 569
Hepatitis C and hepatocellular carcinoma
Di Bisceglie, A. M. (1997) · Hepatology · doi:10.1002/hep.510260706 · Cited by 558
Impact of alcohol on the histological and clinical progression of Hepatitis C infection
Wiley, T. E., McCarthy, M., Breidi, L., McCarthy, M., & Layden, T. J. (1998) · Hepatology · doi:10.1002/hep.510280330 · Cited by 436
Characteristics of patients with dual infection by hepatitis B and C viruses
Zarski, J.-P., Bohn, B., Bastie, A., Pawlotsky, J.-M., Baud, M., Bost-Bezeaux, F., van Nhieu, J. T., Seigneurin, J.-M., Buffet, C., & Dhumeaux, D. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80198-0 · Cited by 374
THE EPIDEMIOLOGY OF VIRAL HEPATITIS IN THE UNITED STATES
Alter, M. J., & Mast, E. E. (1994) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00146-1 · Cited by 324
Bennett, W. G., Inoue, Y., Beck, J. R., Wong, J. B., Pauker, S. G., & Davis, G. L. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-10-199711150-00001 · Cited by 315
Mathurin, P., Moussalli, J., Cadranel, J.-F., Thibault, V., Charlotte, F., Dumouchel, P., Cazier, A., Huraux, J.-M., Devergie, B., Vidaud, M., et al. (1998) · Hepatology · doi:10.1002/hep.510270333 · Cited by 302
EASL International Consensus Conference on Hepatitis C
Marcellin, P. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80366-3 · Cited by 268
Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis
Tremolada, F., Casarin, C., Alberti, A., Drago, C., Tagger, A., Ribero, M. L., & Realdi, G. (1992) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80657-9 · Cited by 263
The natural course of chronic hepatitis C
Iwarson, S. (1994) · FEMS Microbiology Reviews · doi:10.1016/0168-6445(94)90033-7 · Cited by 238
Non-A, Non-B Post-Transfusion Hepatitis: Looking Back in the Second Decade
Koretz, R. L., Abbey, H., Coleman, E., & Gitnick, G. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-2-199307150-00003 · Cited by 233
Modeling the Hepatitis C Virus Epidemic in France
Deuffic, S., Buffat, L., Poynard, T., & Valleron, A.-J. (1999) · Hepatology · doi:10.1002/hep.510290528 · Cited by 210
Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients.
Salerno, F., Borroni, G., Moser, P., Badalamenti, S., Cassarà, L., Maggi, A. C., Fusini, M., & Cesana, B. M. (1993) · PubMed · Cited by 203
The Increasing Incidence of Hepatocellular Carcinoma
Ince, N., & Wands, J. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401009 · Cited by 189
Pretreatment Evaluation of Chronic Hepatitis C: Risks, Benefits, and Costs
Wong, J. B., Bennett, W. G., Koff, R. S., & Pauker, S. G. (1998) · JAMA · doi:10.1001/jama.280.24.2088 · Cited by 188
Liver transplantation for hepatitis C virus-related cirrhosis
Ascher, N. L., Lake, J. R., Emond, J. C., & Roberts, J. P. (1994) · Hepatology · doi:10.1002/hep.1840200708 · Cited by 138
Natural course of chronic hepatitis C.
Takahashi, M., Yamada, G., Miyamoto, R., Doi, T., Endo, H., & Tsuji, T. (1993) · PubMed · Cited by 123
Christensen, E., Krintel, J. J., Hansen, S. M., Johansen, J. K., & Juhl, E. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909089247 · Cited by 82
Addict death rates during a four-year posttreatment follow-up.
Joe, G. W., Lehman, W. E. K., & Simpson, D. D. (1982) · American Journal of Public Health · doi:10.2105/ajph.72.7.703 · Cited by 81
Births and deaths: preliminary data for 1997.
Sj, V., Rn, A., Ja, M., & Bl, S. (1998) · PubMed · Cited by 75
Yu, M. C., Yuan, J., Ross, R. K., & Govindarajan, S. (1997) · Hepatology · doi:10.1002/hep.510250141 · Cited by 72
Persistence of Viremia in Patients with Type-C Chronic Hepatitis during Long-Term Follow-up
Yousuf, M., Nakano, Y., Tanaka, E., Sodeyama, T., & Kiyosawa, K. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209011189 · Cited by 64
Hepatitis C and the correctional population
Reindollar, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00394-0 · Cited by 64
Occupational Exposure to Hepatitis C Virus: A Dilemma
Alter, M. J. (1994) · Infection Control and Hospital Epidemiology · doi:10.1086/646850 · Cited by 49
Life expectancy biases in clinical decision modeling
Kuntz, K. M., & Weinstein, M. C. (1995) · Medical Decision Making · doi:10.1177/0272989x9501500209 · Cited by 38
Chronic liver disease mortality in the United States, 1979 through 1989.
Hurwitz, E. S., Holman, R. C., Strine, T. W., & Chorba, T. L. (1995) · American Journal of Public Health · doi:10.2105/ajph.85.9.1256 · Cited by 25
Cited by
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00004 · Cited by 1,955
The global burden of hepatitis C
Lavanchy, D. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01934.x · Cited by 1,368
Hepatocellular carcinoma: Recent trends in the United States
El-Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.013 · Cited by 972
Metadata
- Venue
- American Journal of Public Health
- Publisher
- American Public Health Association
- Published
- 2000-10-01
- Volume
- 90
- Issue
- 10
- Pages
- 1562-1569
- ISSN
- 0090-0036 (ISSN-L)
- 1541-0048
- OpenAlex
- W1587896012
- Cited by
- 567
- References
- 43
- FWCI
- 15.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.